Both CD44 and SOX2 CSC-like markers were overexpressed in the C666-1 tumor sphere and the isolated CD44+ NPC cells were found to be more resistant to chemotherapeutic agent[34]. The gene discussed is SOX2; the disease is nasopharyngeal carcinoma.